Product logins

Find logins to all Clarivate products below.


Peripheral Vascular Devices | Market Insights | Europe | 2023

The COVID-19 pandemic had a negative impact on the European PV device market in 2020, and to some extent in 2021 and 2022. Following the impact of the pandemic, increasing physician awareness of the benefits of endovascular techniques over surgical interventions will drive growth in this market. Additionally, the launch of premium-priced devices, emerging clinical data, and improvements in reimbursement will support the European PV device market through the forecast period. However, revenue growth will be limited to some extent due to increasing price competition and ongoing cost constraints.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in Europe from 2019 through 2031.

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…
Report
Heart Valve Devices – Market Insights – Europe
The European heart valve device market will continue to observe moderate growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of THV devices…